These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 20206544

  • 1. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
    Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ.
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
    [Abstract] [Full Text] [Related]

  • 2. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with esophageal cancer.
    Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ.
    Ann Thorac Surg; 2011 Oct; 92(4):1239-42; discussion 1243. PubMed ID: 21867990
    [Abstract] [Full Text] [Related]

  • 3. Analysis of multidisciplinary lung cancer practice.
    Conron M, Phuah S, Steinfort D, Dabscheck E, Wright G, Hart D.
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [Abstract] [Full Text] [Related]

  • 4. Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center.
    Chien CR, Lai MS.
    Am J Med Qual; 2006 Jan; 21(6):408-14. PubMed ID: 17077423
    [Abstract] [Full Text] [Related]

  • 5. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP, Ouwens MM, Vonk-Okhuijsen SY, van der Wel Y, Tjan-Heijnen VC, van den Broek LD, Ho VK, Janssen-Heijnen ML, Groen HJ, Grol RP, Wollersheim HC.
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [Abstract] [Full Text] [Related]

  • 6. The management of non-small-cell lung cancer with oligometastases.
    Downey RJ, Ng KK.
    Chest Surg Clin N Am; 2001 Feb; 11(1):121-32, ix. PubMed ID: 11253594
    [Abstract] [Full Text] [Related]

  • 7. Combined modality therapy for stage III non-small-cell lung cancer.
    Anderson CS, Curran WJ.
    Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
    [Abstract] [Full Text] [Related]

  • 8. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L, Robinson LA, Wagner H.
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [Abstract] [Full Text] [Related]

  • 9. [Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma].
    Jassem J, Biernat W, Drosik K, Dziadziuszko R, Kordek R, Kozielski J, Kowalski DM, Krzakowski M, Nikliński J, Olszewski W, Orłowski T, Ramlau R, Roszkowski-Śliż K, Rzyman W.
    Pneumonol Alergol Pol; 2010 Feb; 78(6):418-31. PubMed ID: 21077034
    [No Abstract] [Full Text] [Related]

  • 10. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M, Baumann M, Deppermann M, Freitag L, Gatzemeier U, Huber R, Passlick B, Serke M, Ukena D.
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of stage I lung cancer.
    Walsh GL, Pisters KM, Stevens C.
    Chest Surg Clin N Am; 2001 Feb; 11(1):17-38, vii. PubMed ID: 11253597
    [Abstract] [Full Text] [Related]

  • 12. Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
    Bordoni R.
    Oncologist; 2008 Sep; 13(9):945-53. PubMed ID: 18779538
    [Abstract] [Full Text] [Related]

  • 13. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
    Patel V, Shrager JB.
    Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
    [Abstract] [Full Text] [Related]

  • 14. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW, Siesling S, Jansen-Landheer ML, Elferink MA, Belderbos J, Coebergh JW, Schramel FM.
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [Abstract] [Full Text] [Related]

  • 15. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M, Hoffknecht P, Droege C, Baisch A, Reinmuth N, Kreuter M, Lange T, Berdel WE.
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
    Reck M, Rosell R, Tiemann M.
    Onkologie; 2012 Aug; 35 Suppl 3():10-3. PubMed ID: 22678019
    [No Abstract] [Full Text] [Related]

  • 17. Stage IIIB non-small-cell lung cancer.
    Rendina EA, Venuta F, De Giacomo T, Furio Coloni G.
    Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
    [Abstract] [Full Text] [Related]

  • 18. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE, Fried D, Morris DE, Socinski MA.
    Oncologist; 2006 Feb; 11(7):809-23. PubMed ID: 16880240
    [Abstract] [Full Text] [Related]

  • 19. [To improve the survival rate of patients suffering from locally advanced non-small cell lung cancer with combination of radiotherapy and chemotherapy].
    Zhu GY.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):88-90. PubMed ID: 17445466
    [No Abstract] [Full Text] [Related]

  • 20. Stage II (T3) lung cancer.
    Allen MS, Jett JR, Kozelsky TF.
    Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.